Skip to content

Drug interactions

Armodafinil + Paclitaxel

Severity: Minor

Armodafinil and Paclitaxel: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Armodafinil may weakly induce CYP3A4, which is one of the pathways that clear paclitaxel. Any reduction in paclitaxel exposure is expected to be small and its clinical significance is unclear.

What this interaction means in plain words

Armodafinil and Paclitaxel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Armodafinil belongs to Central Nervous System; Paclitaxel belongs to Oncology.

Evidence level: Low

Why it happens

Weak CYP3A4 induction by armodafinil may increase paclitaxel metabolism.

What to do

No empiric adjustment is needed. Follow the usual clinical and hematologic response to paclitaxel.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Armodafinil and Paclitaxel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Armodafinil with Paclitaxel?

MediHelp rates the interaction as minor. Armodafinil and Paclitaxel have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Armodafinil may weakly induce CYP3A4, which is one of the pathways that clear paclitaxel. Any reduction in paclitaxel exposure is expected to be small and its clinical significance is unclear.

How serious is the interaction between Armodafinil and Paclitaxel?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empiric adjustment is needed. Follow the usual clinical and hematologic response to paclitaxel.

What other medicines interact with Armodafinil?

MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Elacestrant, Elbasvir / grazoprevir. The full list is on the Armodafinil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in